Dow Inc. enters its October 22 earnings date with the Street turning more cautious in real time, the most newsworthy development this week is not the stock's decline but the analyst actions landing on the final day of the quarter.
Citigroup downgraded Dow to Neutral from Buy on September 30, cutting its target from $35 to $30. On the same day, RBC Capital trimmed its target from $32 to $29 while keeping a Sector Perform rating. UBS moved earlier in the week, lowering its target from $32 to $30 on September 25. The pattern is consistent: across three firms in five days, every action was a cut, and Citi's downgrade removed one of the few remaining Buy ratings. The consensus has settled at Hold, with four buys against thirteen holds and a mean target of $33.81. That implies roughly 22% upside from Tuesday's close of $27.61, but the direction of travel matters as much as the gap. Targets have been moving in one direction for months, and the RBC target of $29 is almost at the current price.
The borrow market tells a story of very low conviction on the short side. Availability is more than 3,200% of short interest, meaning there are roughly 33 shares available to borrow for every one currently shorted. That is an extraordinarily loose lending pool. Short interest is running at about 5% of the free float, down 3.8% on the week after a steady drift lower through September. Cost to borrow has risen 39% over the past week to 0.56%, but the absolute level remains negligible for institutional purposes. The ORTEX short score of 39.9 sits in the bottom third of the universe and has been drifting lower through the month. None of this points to a stock with meaningful short-side conviction behind it.
Options positioning has turned incrementally less defensive over the same period. The put/call ratio is at 0.96, below its 20-day average of 1.03 and almost one and a half standard deviations softer than that mean. It is also well below the 52-week high of 1.19. The direction of travel mirrors what happened to short interest: both measures suggest investors have been reducing downside exposure even as the stock has fallen 9.5% over the past month. That is an unusual combination. The stock is cheaper, but hedgers are pulling back rather than adding protection.
The valuation picture is mixed. Price-to-book has compressed to 1.21 and has fallen roughly 9% over the past 30 days. The PE ratio is 14.4, down about half a turn over the same period. EV/EBITDA is at 6.6. The forward earnings momentum factor scores at the 9th percentile over 30 days and the 8th over 90 days, among the weakest readings in the universe. Against that, the 12-month forward EPS year-on-year increase scores at the 88th percentile, which reflects a low base rather than genuine acceleration as the stock's recent ORTEX score note made clear. The dividend score of 78 remains a feature, though the dividend history in this dataset is stale and should be verified separately.
The bull case rests on margin recovery in Performance and Specialty Plastics from new capacity coming online and anti-dumping measures reducing import pressure, plus structural cost reductions from the ongoing savings programme. Bears point to persistent demand weakness across industrial and consumer end markets, energy cost headwinds, and continuing uncertainty around tariffs and trade. The peer group has been weak across the board: closest peer LYB fell 1.8% on the week, CE dropped 5.5%, and LXU shed 8.1%. Dow's relative outperformance is real but comes in the context of a sector under broad pressure.
The most notable institutional flow comes from BlackRock, which added 8.4 million shares as of August 31, lifting its stake to 8.55% of shares outstanding. Two Sigma added 13.4 million shares over the same period. Those are meaningful additions into a declining stock, though the data reflects August positioning and does not capture September's further leg down. There are no 13D activist filings on the register, and all 13G disclosures are passive in nature.
Wikipedia attention for Dow spiked to a z-score of 3.5 against its own 90-day history as of September 25, a sign of unusually elevated retail interest heading into quarter-end. With earnings on October 22 and three analyst cuts in the final week of the quarter, what the Q3 print reveals about volumes in polyethylene and the pace of the cost programme will determine whether the current target cluster around $29 to $30 starts to look like a floor or a ceiling.
See the live data behind this article on ORTEX.
Open DOW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
